ロード中...
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. NAFLD is considerably more frequent in patients with type 2 diabetes mellitus (T2DM) than in the general population and is also more severe histologically in this group. Sodium-glucose co-transpo...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676552/ https://ncbi.nlm.nih.gov/pubmed/31391764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i28.3664 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|